Change of Insulin Resistance in Hepatitis C Virus-infected Patients Receiving Pegylated Interferon Plus Ribavirin

被引：0
|
作者：
Tseng, Cheng-Hao
Hsu, Yao-Chun
Chang, Chi-Yang
Lin, Chih-Wen
Lin, Jaw-Town
Mo, Lein-Ray
机构：
来源：
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 2015年 / 13卷 / 07期
关键词：
D O I：
10.1016/j.cgh.2015.04.148
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E117 / E117
页数：1
相关论文
共 50 条
  • [21] Dynamics of serum metabolites in patients with chronic hepatitis C receiving pegylated interferon plus ribavirin: A metabolomics analysis
    Saito, Takafumi
    Sugimoto, Masahiro
    Igarashi, Kaori
    Saito, Kaori
    Shao, Li
    Katsumi, Tomohiro
    Tomita, Kyoko
    Sato, Chikako
    Okumoto, Kazuo
    Nishise, Yuko
    Watanabe, Hisayoshi
    Tomita, Masaru
    Ueno, Yoshiyuki
    Soga, Tomoyoshi
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2013, 62 (11): : 1577 - 1586
  • [22] Treatment of hepatitis C virus genotype 2 and 3 with pegylated interferon plus ribavirin
    Rizzetto, M
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 275 - 276
  • [23] Regression of liver fibrosis in hepatitis C virus/HIV-co-infected patients after treatment with pegylated interferon plus ribavirin
    Soriano, Vincent
    Labarga, Pablo
    Ruiz-Sancho, Andres
    Garcia-Samaniego, Javier
    Barreiro, Pablo
    AIDS, 2006, 20 (17) : 2225 - 2227
  • [24] Predisposing factors for development of hepatocellular carcinoma in chronically infected hepatitis C virus patients who underwent pegylated interferon plus ribavirin
    Kim, Sin-Il
    Jin, Young-Joo
    Jang, Jihye
    Lee, Jin-Woo
    Kim, Young Soo
    HEPATOLOGY, 2014, 60 : 878A - 878A
  • [25] Influence of pegylated interferon and ribavirin on insulin resistance and metabolic factors in chronic hepatitis C
    Altin, Zeynep
    Diniz, Gulden
    Colak, Ayfer
    Koyuncu, Betul
    Ozer, Serhat
    Aslan, Fatih
    Unsal, Belkis
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2019, 44 (02): : 170 - 176
  • [26] Impact of Diet and Exercise Intervention On Insulin Resistance and Early Virological Response to Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis C
    Kawaguchi, Yasunori
    Mizuta, Toshihiko
    Kuwashiro, Takuya
    Oza, Noriko
    Takahashi, Hirokazu
    Eguchi, Yuichiro
    Ozaki, Iwata
    Fujimoto, Kazuma
    GASTROENTEROLOGY, 2009, 136 (05) : A791 - A791
  • [27] Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus - Response
    Cuerda, V. J. Moreno
    Conejo, M. Morales
    Rubio, R.
    REVISTA CLINICA ESPANOLA, 2007, 207 (03): : 151 - 151
  • [28] Effects of Host and virus related factors on Interferon-α plus ribavirin and Pegylated-interferon plus ribavirin treatment outcomes in Chronic Hepatitis C patients
    Akram, Madiha
    Idrees, Muhammad
    Zafar, Shamail
    Hussain, Abrar
    Butt, Sadia
    Afzal, Samia
    Rehman, Irshad-ur
    Liaqat, Ali
    Saleem, Sana
    Ali, Muhammad
    Butt, Azeem
    VIROLOGY JOURNAL, 2011, 8
  • [29] Proximal splenic artery embolization allows pegylated interferon and ribavirin combination therapy in chronic hepatitis C virus-infected patients with severe cytopenia
    Annicchiarico, Brigida E.
    Siciliano, Massimo
    Di Stasi, Carmine
    Bombardieri, Giuseppe
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2006, 18 (01) : 119 - 121
  • [30] Pegylated interferon plus ribavirin versus non-pegylated interferon plus ribavirin for chronic hepatitis C - A cochrane systematic review
    Simin, M
    Brok, F
    Stimac, D
    Gluud, C
    Gluud, LL
    HEPATOLOGY, 2005, 42 (04) : 666A - 666A
12345